Advertisement
Artemether-lumefantrine dosing for malaria treatment in young children and pregnant women

June 12, 2018

Artemether-lumefantrine dosing for malaria treatment in young children and pregnant women

Joel Tarning and colleagues investigate the pharmacological properties of artemether-lumefantrine and its main metabolite to inform dosing regimens for treating malaria, particularly in children and pregnant women. Read the Author Summary

Image credit: President's Malaria Initiative, Flickr

PLOS Research News: stay up-to-date with research from across PLOS

PLOS Research News

Get new content from PLOS Medicine in your inbox

Thank you! You have successfully subscribed to the PLOS Medicine newsletter.

Sorry, an error occurred while sending your subscription. Please try again later.

Try again